The DOI matches its Crossref record; 176 of the 176 references it cites were found in a registry or an index.
Wnt signaling in triple-negative breast cancer
Open accessAbstract
Wnt signaling regulates a variety of cellular processes, including cell fate, differentiation, proliferation and stem cell pluripotency. Aberrant Wnt signaling is a hallmark of many cancers. An aggressive subtype of breast cancer, known as triple-negative breast cancer (TNBC), demonstrates dysregulation in canonical and non-canonical Wnt signaling. In this review, we summarize regulators of canonical and non-canonical Wnt signaling, as well as Wnt signaling dysfunction that mediates the progression of TNBC. We review the complex molecular nature of TNBC and the emerging therapies that are currently under investigation for the treatment of this disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Nishimura, R., Osako, T., Nishiyama, Y., Tashima, R., Nakano, M., Fujisue, M., Toyozumi, Y., & Arima, N. (2013) · Oncology · doi:10.1159/000353099 · Cited by 13,166
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Oncomirs—MicroRNAs with a role in cancer
Esquela-Kerscher, A., & Slack, F. J. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1840 · Cited by 5,884
Lehmann, B. D., Bauer, J. A., Chen, X., Sanders, M. E., Chakravarthy, A. B., Shyr, Y., & Pietenpol, J. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci45014 · Cited by 5,592
Wnt/β-Catenin Signaling in Development and Disease
Clevers, H. (2006) · Cell · doi:10.1016/j.cell.2006.10.018 · Cited by 5,568
Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase
Bryant, H. E., Schultz, N., Thomas, H. D., Parker, K. M., Flower, D., Lopez, E., Kyle, S., Meuth, M., Curtin, N. J., & Helleday, T. (2005) · Nature · doi:10.1038/nature03443 · Cited by 5,198
Stöckl, S., Göttl, C., Grifka, J., & Grässel, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350089 · Cited by 4,656
Identification of c- MYC as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566
Elkablawy, M. A., Albasri, A. M., Mohammed, R. A., Hussainy, A. S., Nouh, M. M., & Alhujaily, A. S. (2016) · Saudi Medical Journal · doi:10.15537/smj.2016.2.12285 · Cited by 4,382
Foulkes, W. D., Smith, I. E., & Reis-Filho, J. S. (2010) · New England Journal of Medicine · doi:10.1056/nejmra1001389 · Cited by 4,157
Cell Signaling by Receptor Tyrosine Kinases
Schlessinger, J. (2000) · Cell · doi:10.1016/s0092-8674(00)00114-8 · Cited by 3,774
Trastuzumab — Mechanism of Action and Use in Clinical Practice
Hudis, C. A. (2007) · New England Journal of Medicine · doi:10.1056/nejmra043186 · Cited by 2,585
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
Wnt proteins are lipid-modified and can act as stem cell growth factors
Willert, K., Brown, J. D., Danenberg, E., Duncan, A. W., Weissman, I. L., Reya, T., Yates, J. R., & Nusse, R. (2003) · Nature · doi:10.1038/nature01611 · Cited by 2,257
Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer
Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., He, X., & Perou, C. M. (2010) · Breast Cancer Research · doi:10.1186/bcr2635 · Cited by 2,167
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling
Huang, S.-M. A., Mishina, Y. M., Liu, S., Cheung, A., Stegmeier, F., Michaud, G. A., Charlat, O., Wiellette, E., Zhang, Y., Wiessner, S., et al. (2009) · Nature · doi:10.1038/nature08356 · Cited by 2,037
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
Shah, S. P., Roth, A., Goya, R., Oloumi, A., Ha, G., Zhao, Y., Turashvili, G., Ding, J., Tse, K., Haffari, G., et al. (2012) · Nature · doi:10.1038/nature10933 · Cited by 1,967
Meta-Analysis of BRCA1 and BRCA2 Penetrance
Chen, S., & Parmigiani, G. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.09.1066 · Cited by 1,802
Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation
Kaufman, B., Shapira-Frommer, R., Schmutzler, R. K., Audeh, M. W., Friedlander, M., Balmaña, J., Mitchell, G., Fried, G., Stemmer, S. M., Hubert, A., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.56.2728 · Cited by 1,671
Burstein, M. D., Tsimelzon, A., Poage, G. M., Covington, K. R., Contreras, A., Fuqua, S. A. W., Savage, M. I., Osborne, C. K., Hilsenbeck, S. G., Chang, J. C., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-0432 · Cited by 1,392
Clinical implications of the intrinsic molecular subtypes of breast cancer
Prat, A., Pineda, E., Adamo, B., Galván, P., Fernández, A., Gaba, L., Díez, M., Viladot, M., Arance, A., & Muñoz, M. (2015) · The Breast · doi:10.1016/j.breast.2015.07.008 · Cited by 1,319
Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update
Takebe, N., Miele, L., Harris, P. J., Jeong, W., Bando, H., Kahn, M., Yang, S. X., & Ivy, S. P. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.61 · Cited by 1,298
Downregulation of miRNA-200c Links Breast Cancer Stem Cells with Normal Stem Cells
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., Liu, H., Panula, S. P., Chiao, E., et al. (2009) · Cell · doi:10.1016/j.cell.2009.07.011 · Cited by 1,213
From unwinding to clamping — the DEAD box RNA helicase family
Linder, P., & Jankowsky, E. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3154 · Cited by 1,174
YAP/TAZ incorporation in the β-catenin destruction complex orchestrates the Wnt response
Azzolin, L., Panciera, T., Soligo, S., Enzo, E., Bicciato, S., Dupont, S., Bresolin, S., Frasson, C., Basso, G., Guzzardo, V., et al. (2014) · Cell · doi:10.1016/j.cell.2014.06.013 · Cited by 1,094
Wnt Signaling through Inhibition of β-Catenin Degradation in an Intact Axin1 Complex
Li, V. S. W., Ng, S. S., Boersema, P. J., Low, T. Y., Karthaus, W. R., Gerlach, J. P., Mohammed, S., Heck, A. J. R., Maurice, M. M., Mahmoudi, T., et al. (2012) · Cell · doi:10.1016/j.cell.2012.05.002 · Cited by 889
Structural Basis of Wnt Recognition by Frizzled
Janda, C. Y., Waghray, D., Levin, A. M., Thomas, C., & Garcia, K. C. (2012) · Science · doi:10.1126/science.1222879 · Cited by 875
Polakis, P. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a008052 · Cited by 847
Habas, R., Kato, Y., & He, X. (2001) · Cell · doi:10.1016/s0092-8674(01)00614-6 · Cited by 842
Monounsaturated Fatty Acid Modification of Wnt Protein: Its Role in Wnt Secretion
Takada, R., Satomi, Y., Kurata, T., Ueno, N., Norioka, S., Kondoh, H., Takao, T., & Takada, S. (2006) · Developmental Cell · doi:10.1016/j.devcel.2006.10.003 · Cited by 788
DEAD-box proteins: the driving forces behind RNA metabolism
Rocak, S., & Linder, P. (2004) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1335 · Cited by 772
Dishevelled: The hub of Wnt signaling
Gao, C., & Chen, Y.-G. (2010) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.021 · Cited by 755
Xiong, G., Deng, L., Zhu, J., Rychahou, P. G., & Xu, R. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-1 · Cited by 753
Gucalp, A., Tolaney, S., Isakoff, S. J., Ingle, J. N., Liu, M. C., Carey, L. A., Blackwell, K., Rugo, H., Nabell, L., Forero, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3327 · Cited by 749
Cancer stem cells: The challenges ahead
Medema, J. P. (2013) · Nature Cell Biology · doi:10.1038/ncb2717 · Cited by 741
Wnt Signaling Requires Sequestration of Glycogen Synthase Kinase 3 inside Multivesicular Endosomes
Taelman, V. F., Dobrowolski, R., Plouhinec, J.-L., Fuentealba, L. C., Vorwald, P. P., Gumper, I., Sabatini, D. D., & De Robertis, E. M. (2010) · Cell · doi:10.1016/j.cell.2010.11.034 · Cited by 676
The Xenopus Wnt effector XTcf-3 interacts with Groucho-related transcriptional repressors
Roose, J., Molenaar, M., Peterson, J., Hurenkamp, J., Brantjes, H., Moerer, P., van de Wetering, M., Destrée, O., & Clevers, H. (1998) · Nature · doi:10.1038/26989 · Cited by 674
Molecular biology in breast cancer: Intrinsic subtypes and signaling pathways
Eroles, P., Bosch, A., Alejandro Pérez-Fidalgo, J., & Lluch, A. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.005 · Cited by 624
Frizzled and LRP5/6 Receptors for Wnt/ -Catenin Signaling
MacDonald, B. T., & He, X. (2012) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a007880 · Cited by 612
Lipidic cubic phase injector facilitates membrane protein serial femtosecond crystallography
Weierstall, U., James, D., Wang, C., White, T. A., Wang, D., Liu, W., Spence, J. C. H., Bruce Doak, R., Nelson, G., Fromme, P., et al. (2014) · Nature Communications · doi:10.1038/ncomms4309 · Cited by 583
Ishitani, T., Kishida, S., Hyodo-Miura, J., Ueno, N., Yasuda, J., Waterman, M., Shibuya, H., Moon, R. T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.131-139.2003 · Cited by 541
Wong, H.-C., Bourdelas, A., Krauss, A., Lee, H.-J., Shao, Y., Wu, D., Mlodzik, M., Shi, D.-L., & Zheng, J. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00427-1 · Cited by 533
Wnt/Ca2+ signaling pathway: a brief overview
De, A. (2011) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmr079 · Cited by 523
Wnt/β-Catenin Pathway Activation Is Enriched in Basal-Like Breast Cancers and Predicts Poor Outcome
Khramtsov, A. I., Khramtsova, G. F., Tretiakova, M., Huo, D., Olopade, O. I., & Goss, K. H. (2010) · The American Journal of Pathology · doi:10.2353/ajpath.2010.091125 · Cited by 509
Role of TAZ as Mediator of Wnt Signaling
Azzolin, L., Zanconato, F., Bresolin, S., Forcato, M., Basso, G., Bicciato, S., Cordenonsi, M., & Piccolo, S. (2012) · Cell · doi:10.1016/j.cell.2012.11.027 · Cited by 493
Zeng, X., Huang, H., Tamai, K., Zhang, X., Harada, Y., Yokota, C., Almeida, K., Wang, J., Doble, B., Woodgett, J., et al. (2008) · Development · doi:10.1242/dev.013540 · Cited by 492
A Mechanism for Wnt Coreceptor Activation
Tamai, K., Zeng, X., Liu, C., Zhang, X., Harada, Y., Chang, Z., & He, X. (2004) · Molecular Cell · doi:10.1016/s1097-2765(03)00484-2 · Cited by 490
Lefebvre, V., Dumitriu, B., Penzo-Méndez, A., Han, Y., & Pallavi, B. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.05.019 · Cited by 467
Peiris-Pagès, M., Martinez-Outschoorn, U. E., Pestell, R. G., Sotgia, F., & Lisanti, M. P. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0712-6 · Cited by 465
Tumour cell heterogeneity maintained by cooperating subclones in Wnt-driven mammary cancers
Cleary, A. S., Leonard, T. L., Gestl, S. A., & Gunther, E. J. (2014) · Nature · doi:10.1038/nature13187 · Cited by 465
Structure of the human smoothened receptor bound to an antitumour agent
Wang, C., Wu, H., Katritch, V., Han, G. W., Huang, X.-P., Liu, W., Siu, F. Y., Roth, B. L., Cherezov, V., & Stevens, R. C. (2013) · Nature · doi:10.1038/nature12167 · Cited by 464
WorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
van Amerongen, R., Bowman, A. N., & Nusse, R. (2012) · Cell Stem Cell · doi:10.1016/j.stem.2012.05.023 · Cited by 445
The DIX domain of Dishevelled confers Wnt signaling by dynamic polymerization
Schwarz-Romond, T., Fiedler, M., Shibata, N., Butler, P. J. G., Kikuchi, A., Higuchi, Y., & Bienz, M. (2007) · Nature Structural & Molecular Biology · doi:10.1038/nsmb1247 · Cited by 435
β-Trcp couples β-catenin phosphorylation-degradation and regulates Xenopus axis formation
Liu, C., Kato, Y., Zhang, Z., Do, V. M., Yankner, B. A., & He, X. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6273 · Cited by 398
Zeng, Y. A., & Nusse, R. (2010) · Cell Stem Cell · doi:10.1016/j.stem.2010.03.020 · Cited by 396
Geyer, F. C., Lacroix-Triki, M., Savage, K., Arnedos, M., Lambros, M. B., MacKay, A., Natrajan, R., & Reis-Filho, J. S. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.205 · Cited by 373
Shubbar, E., Kovács, A., Hajizadeh, S., Parris, T. Z., Nemes, S., Gunnarsdóttir, K., Einbeigi, Z., Karlsson, P., & Helou, K. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-1 · Cited by 373
Structural basis of Smoothened regulation by its extracellular domains
Byrne, E. F. X., Sircar, R., Miller, P. S., Hedger, G., Luchetti, G., Nachtergaele, S., Tully, M. D., Mydock-McGrane, L., Covey, D. F., Rambo, R. P., et al. (2016) · Nature · doi:10.1038/nature18934 · Cited by 360
Subtyping of triple‐negative breast cancer: Implications for therapy
Abramson, V. G., Lehmann, B. D., Ballinger, T. J., & Pietenpol, J. A. (2015) · Cancer · doi:10.1002/cncr.28914 · Cited by 333
MicroRNA-374a activates Wnt/β-catenin signaling to promote breast cancer metastasis
Cai, J., Guan, H., Fang, L., Yang, Y., Zhu, X., Yuan, J., Wu, J., & Li, M. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65871 · Cited by 331
Jang, G.-B., Kim, J.-Y., Cho, S.-D., Park, K.-S., Jung, J.-Y., Lee, H.-Y., Hong, I.-S., & Nam, J.-S. (2015) · Scientific Reports · doi:10.1038/srep12465 · Cited by 328
FZD7 has a critical role in cell proliferation in triple negative breast cancer
Yang, L., Wu, X., Wang, Y., Zhang, K., Wu, J., Yuan, Y.-C., Deng, X., Chen, L., Kim, C. C. H., Lau, S., et al. (2011) · Oncogene · doi:10.1038/onc.2011.145 · Cited by 297
Tamoxifen (ICI46,474) as a targeted therapy to treat and prevent breast cancer
Jordan, V. C. (2006) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706399 · Cited by 292
Dishevelled Proteins Lead to Two Signaling Pathways
Li, L., Yuan, H., Xie, W., Mao, J., Caruso, A. M., McMahon, A., Sussman, D. J., & Wu, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.1.129 · Cited by 290
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) (2008) · The Lancet · doi:10.1016/s0140-6736(08)60069-0 · Cited by 279
ERG induces androgen receptor-mediated regulation of SOX9 in prostate cancer
Cai, C., Wang, H., He, H. H., Chen, S., He, L., Ma, F., Mucci, L., Wang, Q., Fiore, C., Sowalsky, A. G., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66666 · Cited by 273
PARP inhibitors in the management of breast cancer: current data and future prospects
Livraghi, L., & Garber, J. E. (2015) · BMC Medicine · doi:10.1186/s12916-015-0425-1 · Cited by 269
Interactions between SOX factors and Wnt/β‐catenin signaling in development and disease
Kormish, J. D., Sinner, D., & Zorn, A. M. (2010) · Developmental Dynamics · doi:10.1002/dvdy.22046 · Cited by 266
ROR1 Is Expressed in Human Breast Cancer and Associated with Enhanced Tumor-Cell Growth
Zhang, S., Chen, L., Cui, B., Chuang, H.-Y., Yu, J., Wang-Rodriguez, J., Tang, L., Chen, G., Basak, G. W., & Kipps, T. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0031127 · Cited by 260
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat
Tate, C. R., Rhodes, L. V., Segar, H. C., Driver, J. L., Pounder, F. N., Burow, M. E., & Collins-Burow, B. M. (2012) · Breast Cancer Research · doi:10.1186/bcr3192 · Cited by 260
Mohammed, M. K., Shao, C., Wang, J., Wei, Q., Wang, X., Collier, Z., Tang, S., Liu, H., Zhang, F., Huang, J., et al. (2016) · Genes & Diseases · doi:10.1016/j.gendis.2015.12.004 · Cited by 259
Wnt signaling in triple negative breast cancer is associated with metastasis
Dey, N., Barwick, B. G., Moreno, C. S., Ordanic-Kodani, M., Chen, Z., Oprea-Ilies, G., Tang, W., Catzavelos, C., Kerstann, K. F., Sledge, G. W., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-537 · Cited by 255
Structural basis for Smoothened receptor modulation and chemoresistance to anticancer drugs
Wang, C., Wu, H., Evron, T., Vardy, E., Han, G. W., Huang, X.-P., Hufeisen, S. J., Mangano, T. J., Urban, D. J., Katritch, V., et al. (2014) · Nature Communications · doi:10.1038/ncomms5355 · Cited by 253
Minami, Y., Oishi, I., Endo, M., & Nishita, M. (2010) · Developmental Dynamics · doi:10.1002/dvdy.21991 · Cited by 240
Prat, A., Carey, L. A., Adamo, B., Vidal, M., Tabernero, J., Cortés, J., Parker, J. S., Perou, C. M., & Baselga, J. (2014) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/dju152 · Cited by 233
Kahlert, U. D., Maciaczyk, D., Doostkam, S., Orr, B. A., Simons, B., Bogiel, T., Reithmeier, T., Prinz, M., Schubert, J., Niedermann, G., et al. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.05.024 · Cited by 231
Tauriello, D. V. F., Jordens, I., Kirchner, K., Slootstra, J. W., Kruitwagen, T., Bouwman, B. A. M., Noutsou, M., Rüdiger, S. G. D., Schwamborn, K., Schambony, A., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1114802109 · Cited by 230
Triple negative breast cancer - prognostic factors and survival
Ovcaricek, T., Frkovic, S., Matos, E., Mozina, B., & Borstnar, S. (2011) · Radiology and Oncology · doi:10.2478/v10019-010-0054-4 · Cited by 226
Liu, Y.-R., Jiang, Y.-Z., Xu, X.-E., Yu, K.-D., Jin, X., Hu, X., Zuo, W.-J., Hao, S., Wu, J., Liu, G.-Y., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0690-8 · Cited by 226
Oncogenic role of DDX3 in breast cancer biogenesis
Botlagunta, M., Vesuna, F., Mironchik, Y., Raman, A., Lisok, A., Winnard, P., Mukadam, S., Van Diest, P., Chen, J. H., Farabaugh, P., et al. (2008) · Oncogene · doi:10.1038/onc.2008.33 · Cited by 221
Wu, G., Huang, H., Abreu, J. G., & He, X. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004926 · Cited by 216
Ishitani, T., Ninomiya-Tsuji, J., & Matsumoto, K. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.4.1379-1389.2003 · Cited by 212
The molecular profile of luminal B breast cancer
Creighton, C. (2012) · Biologics: Targets and Therapy · doi:10.2147/btt.s29923 · Cited by 212
Impact of breast cancer subtypes and patterns of metastasis on outcome
Kast, K., Link, T., Friedrich, K., Petzold, A., Niedostatek, A., Schoffer, O., Werner, C., Klug, S. J., Werner, A., Gatzweiler, A., et al. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3341-3 · Cited by 209
Chakrabarti, R., Wei, Y., Hwang, J., Hang, X., Andres Blanco, M., Choudhury, A., Tiede, B., Romano, R.-A., DeCoste, C., Mercatali, L., et al. (2014) · Nature Cell Biology · doi:10.1038/ncb3040 · Cited by 207
LRP6 overexpression defines a class of breast cancer subtype and is a target for therapy
Liu, C.-C., Prior, J., Piwnica-Worms, D., & Bu, G. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911220107 · Cited by 207
Fiedler, M., Mendoza-Topaz, C., Rutherford, T. J., Mieszczanek, J., & Bienz, M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1017063108 · Cited by 206
Gong, Y., Bourhis, E., Chiu, C., Stawicki, S., DeAlmeida, V. I., Liu, B. Y., Phamluong, K., Cao, T. C., Carano, R. A. D., Ernst, J. A., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012682 · Cited by 206
RNA Helicase DDX3 Is a Regulatory Subunit of Casein Kinase 1 in Wnt–β-Catenin Signaling
Cruciat, C.-M., Dolde, C., de Groot, R. E. A., Ohkawara, B., Reinhard, C., Korswagen, H. C., & Niehrs, C. (2013) · Science · doi:10.1126/science.1231499 · Cited by 206
Crystal structures of the extracellular domain of LRP6 and its complex with DKK1
Cheng, Z., Biechele, T., Wei, Z., Morrone, S., Moon, R. T., Wang, L., & Xu, W. (2011) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.2139 · Cited by 202
Structural Basis of Wnt Signaling Inhibition by Dickkopf Binding to LRP5/6
Ahn, V. E., Chu, M. L.-H., Choi, H.-J., Tran, D., Abo, A., & Weis, W. I. (2011) · Developmental Cell · doi:10.1016/j.devcel.2011.09.003 · Cited by 201
Jiang, X., Charlat, O., Zamponi, R., Yang, Y., & Cong, F. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.03.015 · Cited by 193
Wu, Z., Wu, Q., Wang, C., Wang, X., Huang, J., Zhao, J., Mao, S., Zhang, G., Xu, X., & Zhang, N. (2011) · Cancer · doi:10.1002/cncr.25860 · Cited by 192
Isobe, T., Hisamori, S., Hogan, D. J., Zabala, M., Hendrickson, D. G., Dalerba, P., Cai, S., Scheeren, F., Kuo, A. H., Sikandar, S. S., et al. (2014) · eLife · doi:10.7554/elife.01977 · Cited by 188
Targeting ROR1 Inhibits Epithelial–Mesenchymal Transition and Metastasis
Cui, B., Zhang, S., Chen, L., Yu, J., Widhopf, G. F., Fecteau, J.-F., Rassenti, L. Z., & Kipps, T. J. (2013) · Cancer Research · doi:10.1158/0008-5472.can-12-3832 · Cited by 187
DEAD box RNA helicase functions in cancer
Fuller-Pace, F. V. (2013) · RNA Biology · doi:10.4161/rna.23312 · Cited by 185
Wnt Signalosome Assembly by DEP Domain Swapping of Dishevelled
Gammons, M. V., Renko, M., Johnson, C. M., Rutherford, T. J., & Bienz, M. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.08.026 · Cited by 184
Sussman, D. J., Klingensmith, J., Salinas, P., Adams, P. S., Nusse, R., & Perrimon, N. (1994) · Developmental Biology · doi:10.1006/dbio.1994.1297 · Cited by 183
Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression
Nikolova, V., Koo, C.-Y., Ibrahim, S. A., Wang, Z., Spillmann, D., Dreier, R., Kelsch, R., Fischgräbe, J., Smollich, M., Rossi, L. H., et al. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp001 · Cited by 183
Dijksterhuis, J. P., Petersen, J., & Schulte, G. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12364 · Cited by 182
β-Catenin Is Required for the Tumorigenic Behavior of Triple-Negative Breast Cancer Cells
Xu, J., Prosperi, J. R., Choudhury, N., Olopade, O. I., & Goss, K. H. (2015) · PLOS ONE · doi:10.1371/journal.pone.0117097 · Cited by 180
Nishita, M., Itsukushima, S., Nomachi, A., Endo, M., Wang, Z., Inaba, D., Qiao, S., Takada, S., Kikuchi, A., & Minami, Y. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00177-10 · Cited by 177
Multiple functions of the noncanonical Wnt pathway
Gómez‐Orte, E., Sáenz‐Narciso, B., Moreno, S., & Cabello, J. (2013) · Trends in Genetics · doi:10.1016/j.tig.2013.06.003 · Cited by 176
Lindvall, C., Evans, N. C., Zylstra, C. R., Li, Y., Alexander, C. M., & Williams, B. O. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607571200 · Cited by 169
Wnt Antagonists Bind through a Short Peptide to the First β-Propeller Domain of LRP5/6
Bourhis, E., Wang, W., Tam, C., Hwang, J., Zhang, Y., Spittler, D., Huang, O. W., Gong, Y., Estevez, A., Zilberleyb, I., et al. (2011) · Structure · doi:10.1016/j.str.2011.07.005 · Cited by 168
Single-cell imaging of Wnt palmitoylation by the acyltransferase porcupine
Gao, X., & Hannoush, R. N. (2014) · Nature Chemical Biology · doi:10.1038/nchembio.1392 · Cited by 167
Wnt5a induces homodimerization and activation of Ror2 receptor tyrosine kinase
Liu, Y., Rubin, B., Bodine, P. V. N., & Billiard, J. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21848 · Cited by 165
Jang, G.-B., Hong, I.-S., Kim, R.-J., Lee, S.-Y., Park, S.-J., Lee, E.-S., Park, J. H., Yun, C.-H., Chung, J.-U., Lee, K.-J., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-2041 · Cited by 163
Inhibition of Tankyrases Induces Axin Stabilization and Blocks Wnt Signalling in Breast Cancer Cells
Bao, R., Christova, T., Song, S., Angers, S., Yan, X., & Attisano, L. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048670 · Cited by 161
Pogoda, K., Niwińska, A., Murawska, M., & Pieńkowski, T. (2013) · Medical Oncology · doi:10.1007/s12032-012-0388-4 · Cited by 159
New Strategies in Breast Cancer: Immunotherapy
Pusztai, L., Karn, T., Safonov, A. M., Abu-Khalaf, M. M., & Bianchini, G. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1315 · Cited by 157
Crosstalk between the Androgen Receptor and β-Catenin in Castrate-Resistant Prostate Cancer
Wang, G., Wang, J., & Sadar, M. D. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1718 · Cited by 156
Dejmek, J. S., Säfholm, A., Nielsen, C. K., Andersson, T., & Leandersson, K. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.02354-05 · Cited by 146
The Wnt Co-Receptor Lrp6 Is Required for Normal Mouse Mammary Gland Development
Lindvall, C. J., Diegel, C. R., Evans, N. C., West, R. A., Dykema, K. J., Furge, K. A., & Williams, B. O. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005813 · Cited by 137
Moon, Y. W., Lee, S. H., Park, B., Kim, E., Kim, S. I., Koo, J. S., Park, S., Kim, M. J., Chung, H. C., Kim, J.-H., et al. (2013) · BMC Cancer · doi:10.1186/1471-2407-13-583 · Cited by 134
DEAD-box helicase DP103 defines metastatic potential of human breast cancers
Shin, E. M., Hay, H. S., Lee, M. H., Goh, J. N., Tan, T. Z., Sen, Y. P., Lim, S. W., Yousef, E. M., Ong, H. T., Thike, A. A., et al. (2014) · Journal of Clinical Investigation · doi:10.1172/jci73451 · Cited by 134
Self-citationBadders, N. M., Goel, S., Clark, R. J., Klos, K. S., Kim, S. Y., Bafico, A., Lindvall, C. J., Williams, B. O., & Alexander, C. M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006594 · Cited by 133
Chiacchiera, F., Rossi, A., Jammula, S., Piunti, A., Scelfo, A., Ordóñez‐Morán, P., Huelsken, J., Koseki, H., & Pasini, D. (2015) · Cell stem cell · doi:10.1016/j.stem.2015.09.019 · Cited by 129
microRNAs in breast cancer: regulatory roles governing the hallmarks of cancer
Goh, J. N., Loo, S. Y., Datta, A., Siveen, K. S., Yap, W. N., Cai, W., Shin, E. M., Wang, C., Kim, J. E., Chan, M., et al. (2015) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12176 · Cited by 125
Self-citationIbrahim, S., Hassan, H., Vilardo, L., Katakam, S. K., Kumar, A. V., Kelsch, R., Schneider, C., Kiesel, L., Eich, H. T., Zucchi, I., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0085737 · Cited by 120
Self-citationPrasad, C. P., Mirza, S., Sharma, G., Prashad, R., DATTAGUPTA, S., Rath, G., & Ralhan, R. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.06.019 · Cited by 118
Weisman, P. S., Ng, C. K. Y., Brogi, E., Eisenberg, R. E. K., Won, H. H., Piscuoglio, S., Filippo, M. R. D., Ioris, R. A., Akram, M. M., Norton, L., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.39 · Cited by 116
A Role for DEAD Box 1 at DNA Double-Strand Breaks
Li, L., Monckton, E. A., & Godbout, R. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.01053-08 · Cited by 115
Disulfide Bond Requirements for Active Wnt Ligands
MacDonald, B. T., Hien, A., Zhang, X., Iranloye, O., Virshup, D. M., Waterman, M. L., & He, X. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.575027 · Cited by 101
Mohammadi‐Yeganeh, S., Paryan, M., Arefian, E., Vasei, M., Ghanbarian, H., Mahdian, R., Karimipoor, M., & Soleimani, M. (2016) · Tumor Biology · doi:10.1007/s13277-015-4513-9 · Cited by 101
Golubkov, V. S., Chekanov, A. V., Cieplak, P., Aleshin, A. E., Chernov, A. V., Zhu, W., Radichev, I., Zhang, D., Dong, P. D. S., & Strongin, A. Y. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.165159 · Cited by 99
Pistelli, M., Caramanti, M., Biscotti, T., Santinelli, A., Pagliacci, A., Lisa, M. D., Ballatore, Z., Ridolfi, F., Maccaroni, E., Bracci, R., et al. (2014) · Cancers · doi:10.3390/cancers6031351 · Cited by 94
Schech, A. J., Kazi, A. A., Yu, S. L., Shah, P., & Sabnis, G. J. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0778 · Cited by 94
Frizzled7: A Promising Achilles’ Heel for Targeting the Wnt Receptor Complex to Treat Cancer
Phesse, T. J., Flanagan, D. J., & Vincan, E. (2016) · Cancers · doi:10.3390/cancers8050050 · Cited by 93
Avery‐Kiejda, K. A., Braye, S. G., Mathe, A., Forbes, J., & Scott, R. J. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-51 · Cited by 91
Fatty acid synthase regulates invasion and metastasis of colorectal cancer via Wnt signaling pathway
Wang, H.-Y., Xi, Q., & Wu, G.-H. (2016) · Cancer Medicine · doi:10.1002/cam4.711 · Cited by 91
Dishevelled, a Wnt signalling component, is involved in mitotic progression in cooperation with Plk1
Kikuchi, K., Niikura, Y., Kitagawa, K., & Kikuchi, A. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.221 · Cited by 88
Rangel, M. C., Bertolette, D. C., de Castro, N. P., Klauzińska, M., Cuttitta, F. F., & Salomon, D. S. (2016) · Breast Cancer Research and Treatment · doi:10.1007/s10549-016-3746-7 · Cited by 88
Signalling Pathways Implicated in Early Mammary Gland Morphogenesis and Breast Cancer
Howard, B. A., & Ashworth, A. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020112 · Cited by 87
Jiang, Q., He, M., Guan, S., Ma, M., Wu, H., Yu, Z., Jiang, L., Wang, Y., Zong, X., Jin, F., et al. (2015) · Tumor Biology · doi:10.1007/s13277-015-4342-x · Cited by 87
Taipaleenmäki, H., Farina, N. H., van Wijnen, A. J., Stein, J. L., Hesse, E., Stein, G. S., & Lian, J. B. (2016) · Oncotarget · doi:10.18632/oncotarget.12593 · Cited by 87
British Society of Breast Radiology Annual Scientific Meeting 2016
Azmil, A., Bansal, G. J., Davies, E. L., Wallis, M., Kilburn‐Toppin, F., Taylor-Phillip, S., Buckley, A., Healy, N. A., Quinn, A., O’Keeffe, S., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-016-0766-5 · Cited by 86
Wang, D., Huang, J., & Hu, Z. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.011932 · Cited by 85
Corda, G., Sala, G., Lattanzio, R., Iezzi, M., Sallese, M., Fragassi, G., Lamolinara, A., Mirza, H., Barcaroli, D., Ermler, S., et al. (2016) · The Journal of Pathology · doi:10.1002/path.4841 · Cited by 82
WNT/β-Catenin Signaling Regulates Multiple Steps of Myogenesis by Regulating Step-Specific Targets
Suzuki, A., Pelikan, R. C., & Iwata, J. (2015) · Molecular and Cellular Biology · doi:10.1128/mcb.01180-14 · Cited by 80
Crystal Structure of the Frizzled-Like Cysteine-Rich Domain of the Receptor Tyrosine Kinase MuSK
Stiegler, A. L., Burden, S. J., & Hubbard, S. R. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.091 · Cited by 79
Arce-Salinas, C., Martínez, M. C. R., Hanna, W. M., Bedard, P. L., & Warner, E. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2013.49.8899 · Cited by 76
Wang, H., He, L., Ma, F., Regan, M. M., Balk, S. P., Richardson, A. L., & Yuan, X. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.419184 · Cited by 73
Sgroi, D. C., Chapman, J.-A. W., Badovinac-Črnjević, T., Zarrella, E., Binns, S., Zhang, Y., Schnabel, C. A., Erlander, M. G., Pritchard, K. I., Han, L., et al. (2016) · Breast Cancer Research · doi:10.1186/s13058-015-0660-6 · Cited by 73
Henry, C. E., Quadir, A., Hawkins, N. J., Jary, E., Llamosas, E., Kumar, D., Daniels, B. J., Ward, R. L., & Ford, C. E. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1824-y · Cited by 72
Atkinson, R. L., Yang, W. T., Rosen, D. G., Landis, M. D., Wong, H. H., Lewis, M. T., Creighton, C. J., Sexton, K. R., Hilsenbeck, S. G., Şahin, A. A., et al. (2013) · Breast Cancer Research · doi:10.1186/bcr3471 · Cited by 71
Kai, M., Kanaya, N., Wu, S. V., Mendez‐Dorantes, C., Nguyen, D. M., Luu, T. H., & Chen, S. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3376-5 · Cited by 67
Yin, S., Xu, L., Bonfil, R. D., Banerjee, S., Sarkar, F. H., Sethi, S. N., & Reddy, K. B. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-1090 · Cited by 67
Maternal Wnt/STOP signaling promotes cell division during early Xenopus embryogenesis
Huang, Y., Anvarian, Z., Döderlein, G., Acebrón, S. P., & Niehrs, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423533112 · Cited by 65
Solzak, J. P., Atale, R. V., Hancock, B. A., Sinn, A. L., Pollok, K. E., Jones, D. R., & Radovich, M. (2017) · npj Breast Cancer · doi:10.1038/s41523-017-0016-8 · Cited by 61
Xie, M., Vesuna, F., Botlagunta, M., Bol, G. M., Irving, A., Bergman, Y., Hosmane, R. S., Katō, Y., Winnard, P. T., & Raman, V. (2015) · Oncotarget · doi:10.18632/oncotarget.4898 · Cited by 58
Ciupek, A., Rechoum, Y., Gu, G., Gelsomino, L., Beyer, A. R., Brusco, L., Covington, K. R., Tsimelzon, A. I., & Fuqua, S. A. W. (2015) · Breast Cancer Research and Treatment · doi:10.1007/s10549-015-3609-7 · Cited by 57
SPDEF Functions as a Colorectal Tumor Suppressor by Inhibiting β-Catenin Activity
Noah, T. K., Lo, Y., Price, A., Chen, G., King, E. C., Washington, M. K., Aronow, B. J., & Shroyer, N. F. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.01.043 · Cited by 54
Mouse Models for Cancer Stem Cell Research
Cheng, L., Ramesh, A. V., Flesken‐Nikitin, A., Choi, J., & Nikitin, A. Y. (2009) · Toxicologic Pathology · doi:10.1177/0192623309354109 · Cited by 53
Hilborn, E., Gacic, J., Fornander, T., Nordenskjöld, B. A., Stål, O., & Jansson, A. (2016) · British Journal of Cancer · doi:10.1038/bjc.2015.464 · Cited by 53
Merino, V. F., Nguyen, N., Jin, K., Sadik, H., Cho, S., Korangath, P. C., Han, L., Foster, Y. M. N., Zhou, X., Zhang, Z., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1619 · Cited by 50
Cisplatin and TRAIL enhance breast cancer stem cell death
Reddy, K. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1085 · Cited by 49
Xu, H., Yan, Y., Deb, S., Rangasamy, D., Germann, M., Malaterre, J., Eder, N., Ward, R. L., Hawkins, N. J., Tothill, R. W., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.10.059 · Cited by 47
Johnson, N., Dudbridge, F., Orr, N., Gibson, L., Jones, M. E., Schoemaker, M. J., Folkerd, E. J., Haynes, B. P., Hopper, J. L., Southey, M. C., et al. (2014) · Breast Cancer Research · doi:10.1186/bcr3662 · Cited by 45
Role of MCP-1 in alcohol-induced aggressiveness of colorectal cancer cells
Xu, M., Wang, S., Qi, Y., Chen, L., Frank, J. A., Yang, X. H., Zhang, Z., Shi, X., & Luo, J. (2015) · Molecular Carcinogenesis · doi:10.1002/mc.22343 · Cited by 42
Ryk is essential for Wnt-5a-dependent invasiveness in human glioma
Habu, M., Koyama, H., Kishida, M., Kamino, M., Iijima, M., Fuchigami, T., Tokimura, H., Ueda, M., Tokudome, M., Koriyama, C., et al. (2014) · The Journal of Biochemistry · doi:10.1093/jb/mvu015 · Cited by 42
β-Catenin Expression Enhances IL-7 Receptor Signaling in Thymocytes during Positive Selection
Yu, Q., Xu, M., & Sen, J. M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.126 · Cited by 40
Samatanga, B., & Klostermeier, D. (2014) · Nucleic Acids Research · doi:10.1093/nar/gku747 · Cited by 39
Regulating the response to targeted MEK inhibition in melanoma
Conrad, W. H., Swift, R. D., Biechele, T. L., Kulikauskas, R. M., Moon, R. T., & Chien, A. J. (2012) · Cell Cycle · doi:10.4161/cc.21645 · Cited by 37
Concomitant activation of Wnt pathway and loss of mismatch repair function in human melanoma
Castiglia, D., Bernardini, S., Alvino, E., Pagani, E., Luca, N. D., Falcinelli, S., Pacchiarotti, A., Bonmassar, E., Zambruno, G., & D’Atri, S. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20567 · Cited by 36
Yasuhara, R., Irié, T., Suzuki, K., Sawada, T., Miwa, N., Sasaki, A., Tsunoda, Y., Nakamura, S., & Mishima, K. (2015) · Experimental Cell Research · doi:10.1016/j.yexcr.2015.09.003 · Cited by 33
Moore, H. C., Jordan, L. B., Bray, S. E., Baker, L., Quinlan, P., Purdie, C. A., Thompson, A. M., Bourdon, J., & Fuller-Pace, F. V. (2010) · Oncogene · doi:10.1038/onc.2010.381 · Cited by 33
CDK1 phosphorylation of TAZ in mitosis inhibits its oncogenic activity
Zhang, L., Chen, X., Stauffer, S., Yang, S., Chen, Y., & Dong, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5189 · Cited by 33
Sparano, J. A. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.57.7890 · Cited by 26
The Fanconi anemia pathway has a dual function in Dickkopf-1 transcriptional repression
Huard, C., Tremblay, C. S., Magron, A., Lévesque, G., & Carreau, M. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1314226111 · Cited by 15
Tudoran, O. M., Şoriţău, O., Bălăcescu, L., Vișan, S., Bărbos, O., Cojocneanu, R., Bălăcescu, O., & Berindan‐Neagoe, I. (2015) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-015-2522-z · Cited by 11
Solzak, J. P., Atale, R. V., Hancock, B. A., & Radovich, M. (2015) · Cancer Research · doi:10.1158/1538-7445.am2015-5340 · Cited by 1
Cited by
Targeting cancer stem cell pathways for cancer therapy
Yang, L., Shi, P., Zhao, G., Xu, J., Peng, W., Zhang, J., Zhang, G., Wang, X., Dong, Z., Chen, F., et al. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0110-5 · Cited by 1,906
Apigenin in cancer therapy: anti-cancer effects and mechanisms of action
Yan, X., Qi, M., Li, P., Zhan, Y., & Shao, H. (2017) · Cell & Bioscience · doi:10.1186/s13578-017-0179-x · Cited by 545
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells
Kröger, C., Afeyan, A., Mraz, J., Eaton, E. N., Reinhardt, F., Khodor, Y. L., Thiru, P., Bierie, B., Ye, X., Burge, C. B., et al. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1812876116 · Cited by 499
Redox Signaling by Reactive Electrophiles and Oxidants
Parvez, S., Long, M. J. C., Poganik, J. R., & Aye, Y. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00698 · Cited by 359
Triple-Negative Breast Cancer: A Review of Conventional and Advanced Therapeutic Strategies
Medina, M. A., Oza, G., Sharma, A., Arriaga, L. G., Hernández Hernández, J. M., Rotello, V. M., & Ramirez, J. T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17062078 · Cited by 333
Metadata
- Authors
- Pohl, S.-G., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A.
- Venue
- Oncogenesis
- Published
- 2017-04-03
- Volume
- 6
- Issue
- 4
- Pages
- e310-e310
- ISSN
- 2157-9024 (ISSN-L)
- OpenAlex
- W2604586440
- Cited by
- 296
- References
- 176
- FWCI
- 12.23
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.